Alprazolam
- Product NDC
- 59762-0057
- 11-digit product format
- 597620057
- Labeler code
- 59762
- Product ID
- 59762-0057_70f0098e-50b5-4e61-b4e0-141a55d92267
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- alprazolam
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Mylan Pharmaceuticals Inc.
- Application
- NDA021434
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2003-01-17
- Substance
- ALPRAZOLAM
- Active strength
- .5 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Alprazolam
- Brand name suffix
- XR
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ALPRAZOLAM | .5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | YU55MQ3IZY |
| Rxcui | 433798, 433799, 433800, 433801 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 59762-0057-1 | AlprazolamXR | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | | 19 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ALPRAZOLAM | ACTIVE INGREDIENT | YU55MQ3IZY | ALPRAZOLAM XR (ALPRAZOLAM) TABLET, EXTENDED RELEASE [GREENSTONE LLC] | 9 | |
| ALPRAZOLAM | ACTIVE MOIETY | YU55MQ3IZY | ALPRAZOLAM XR (ALPRAZOLAM) TABLET, EXTENDED RELEASE [GREENSTONE LLC] | 9 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | ALPRAZOLAM XR (ALPRAZOLAM) TABLET, EXTENDED RELEASE [GREENSTONE LLC] | 9 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | ALPRAZOLAM XR (ALPRAZOLAM) TABLET, EXTENDED RELEASE [GREENSTONE LLC] | 9 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | ALPRAZOLAM XR (ALPRAZOLAM) TABLET, EXTENDED RELEASE [GREENSTONE LLC] | 9 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | ALPRAZOLAM XR (ALPRAZOLAM) TABLET, EXTENDED RELEASE [GREENSTONE LLC] | 9 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ALPRAZOLAM XR (ALPRAZOLAM) TABLET, EXTENDED RELEASE [GREENSTONE LLC] | 9 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ALPRAZOLAM XR (ALPRAZOLAM) TABLET, EXTENDED RELEASE [GREENSTONE LLC] | 9 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59762-0057 | ALPRAZOLAM XR (ALPRAZOLAM) TABLET, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.] | 19 | Current NDC, Legacy NDC, 1 package rows | 20250507_1338d1c9-7c75-42ed-95f3-9eb1b6fc51d3.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 59762-0057-1 | 59762005701 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (59762-0057-1) | 2003-01-17 | 0000-00-00 | No | No | Current |